Esperion Therapeutics, Inc.
John B. Harlow
Esperion Therapeutics, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John B. Harlow
The proxy statement of Esperion Therapeutics, Inc. reports total compensation of $2,813,103 for John B. Harlow in fiscal 2025, including a base salary of $66,875.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Esperion Therapeutics, Inc.
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Esperion Therapeutics, Inc. | Chief Commercial Officer | $66,875 | $2,813,103 |
Recent activity
No call appearances or filed executive changes recorded yet.